Product NDC: | 48102-006 |
Proprietary Name: | NEO-POLYCIN |
Non Proprietary Name: | NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC |
Active Ingredient(s): | 400; 3.5; 10000 U/g; mg/g; U/g & nbsp; NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 48102-006 |
Labeler Name: | Fera Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA060764 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110715 |
Package NDC: | 48102-006-35 |
Package Description: | 1 TUBE in 1 CARTON (48102-006-35) > 3.5 g in 1 TUBE |
NDC Code | 48102-006-35 |
Proprietary Name | NEO-POLYCIN |
Package Description | 1 TUBE in 1 CARTON (48102-006-35) > 3.5 g in 1 TUBE |
Product NDC | 48102-006 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC |
Dosage Form Name | OINTMENT |
Route Name | OPHTHALMIC |
Start Marketing Date | 20110715 |
Marketing Category Name | ANDA |
Labeler Name | Fera Pharmaceuticals |
Substance Name | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
Strength Number | 400; 3.5; 10000 |
Strength Unit | U/g; mg/g; U/g |
Pharmaceutical Classes | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient],Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Decreased Cell Wall Synthesis & Repair [PE] |